Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.79
Delayed Data
As of 12:27pm ET
 -0.0336 / -1.85%
Today’s Change
1.65
Today|||52-Week Range
5.70
+2.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash239.5M182.5M116.7M36.7M
 
 
 
 
 
Short Term Investment Cash-3.7M18.1M-65.8M10.0M
 
 
 
 
 
Cash & Short Term Investments241.0M194.0M126.6M86.6M
 
 
 
 
 
 
ReceivablesReceivables2.1M1.1M6.3M7.6M
 
 
 
 
 
 
InventoriesInventories24.0M23.2M20.7M15.8M
 
 
 
 
 
 
Current AssetsOther Current Assets6.1M6.2M4.9M4.3M
 
 
 
 
 
Current Assets273.2M224.5M158.5M114.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.8M3.7M3.7M3.7M
 
 
 
 
 
Depreciation-2.5M-2.6M-2.7M-2.9M
 
 
 
 
 
Intangible Assets78.0M76.1M74.1M72.1M
 
 
 
 
 
Other Assets81.2M78.9M76.7M74.7M
 
 
 
 
 
Total Assets355.8M304.6M236.4M190.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable12.0M15.2M15.6M8.3M
 
 
 
 
 
Accrued Expenses18.8M12.9M9.9M11.4M
 
 
 
 
 
Other Current Liabilities48.0M42.8M30.1M28.4M
 
 
 
 
 
Other Liabilities65.5M65.4M49.5M41.8M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt200.9M166.2M177.2M171.5M
 
 
 
 
 
Total Liabilities279.1M244.2M240.9M228.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock3.3M3.3M3.3M3.3M
 
 
 
 
 
Common Equity73.4M57.0M-7.9M-42.0M
 
 
 
 
 
Total Shareholder Equity76.8M60.4M-4.5M-38.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.6M14.6M15.2M15.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.